Page last updated: 2024-11-06

enpiperate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

enpiperate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID77157
CHEMBL ID143228
SCHEMBL ID1088155
MeSH IDM0074081

Synonyms (47)

Synonym
1-methyl-4-piperidyl diphenylglycolate
einecs 222-774-0
qwk86805eb ,
alpha-hydroxy-alpha-phenylbenzeneacetic acid, 1-methyl-4-piperidinyl ester
nsc 172167
unii-qwk86805eb
[3h]1-methyl-4-piperidyl diphenylglycolate
gtpl352
(1-methylpiperidin-4-yl) 2-hydroxy-2,2-di(phenyl)acetate
[3h]4nmpb
[3h](1-methyl-4-piperidyl) 2-hydroxy-2,2-diphenyl-acetate
[3h]enpiperate
nsc172167
nsc-172167
4-nmpb
3608-67-1
benzeneacetic acid, .alpha.-hydroxy-.alpha.-phenyl-, 1-methyl-4-piperidinyl ester
OPREA1_355183
enpiperate
CHEMBL143228 ,
1-methylpiperidin-4-yl 2-hydroxy-2,2-diphenylacetate
1-methylpiperidin-4-yl hydroxy(diphenyl)acetate
(1-methylpiperidin-4-yl) 2-hydroxy-2,2-diphenylacetate
STL112730
AKOS005737518
SCHEMBL1088155
.alpha.-hydroxy-.alpha.-phenylbenzeneacetic acid, 1-methyl-4-piperidinyl ester
n-methyl-4-piperidinyl benzilate
n-methyl-4-piperidyl benzilate
benzilic acid, 1-methyl-4-piperidyl ester
1-methyl-4-piperidyl benzilate
hydroxydiphenylacetic acid 1-methylpiperidin-4-yl ester
4-piperidinol, 1-methyl-, benzilate (ester)
hydroxy-diphenyl-acetic-acid-1-methyl-piperidin-4-yl-ester
hydroxy-diphenyl-acetic acid 1-methyl-piperidin-4-yl ester
1-methyl-4-piperidyl benzylate
1-methyl-4-piperidinyl hydroxy(diphenyl)acetate #
.alpha.-hydroxy-diphenylacetic acid, 1-methyl -4-piperidinyl ester
bdbm50128836
DTXSID20189664
(1-methyl-4-piperidyl) 2-hydroxy-2,2-diphenyl-acetate
methylpiperidin-4-yl 2-hydroxy-2,2-diphenylacetate
4-(3,5)-exocycloproyl-n-methylpiperidyl diphenylhydroxyacetate
1-methylpiperidin-4-yl hydroxydiphenylacetate
Q5379477
CCG-279014
A874441

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" We observed great interindividual differences in the pharmacokinetic behaviour."( [Pharmacokinetics (rats and rabbits) of N-methyl-4- piperidinylbenzilate (Po)3].
Gabrio, T; Göber, B; Höhn, H, 1990
)
0.28

Dosage Studied

ExcerptRelevanceReference
" For example, M-methyl-4-piperidinol benzylate applied in a wide dosage range induced motor hyperactivity without affecting the short-term memory, whereas tropine phenylcyclopentylglycolate provoked motor hyperactivity and memory disorders at equal doses."( [Comparative study of the effect of 3 M-cholinergic blockaders on memory and motor activity in rats].
Sprints, AM; Vinogradov, VV; Zhirova, ND,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Ki0.00010.00010.579710.0000AID142342
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)Ki0.00010.00011.48339.1400AID142342
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)Ki0.00010.00010.68688.2600AID142342
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)Ki0.00010.00010.66618.2600AID142342
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)Ki0.00010.00010.58908.2600AID142342
Muscarinic acetylcholine receptor M3Homo sapiens (human)Ki0.00110.00000.54057.7600AID1253949
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (21)

Processvia Protein(s)Taxonomy
calcium-mediated signalingMuscarinic acetylcholine receptor M3Homo sapiens (human)
regulation of monoatomic ion transmembrane transporter activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
synaptic transmission, cholinergicMuscarinic acetylcholine receptor M3Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M3Homo sapiens (human)
positive regulation of insulin secretionMuscarinic acetylcholine receptor M3Homo sapiens (human)
protein modification processMuscarinic acetylcholine receptor M3Homo sapiens (human)
positive regulation of smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
saliva secretionMuscarinic acetylcholine receptor M3Homo sapiens (human)
acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
ligand-gated ion channel signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M3Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
signaling receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
acetylcholine bindingMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
basal plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
basolateral plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID142342In vitro for binding affinity for muscarinic acetylcholine receptors in homogenized rat brain in the presence of [3H]scopolamine.2000Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
Synthesis, (18)F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors.
AID1253950Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Molecular hybridization yields triazole bronchodilators for the treatment of COPD.
AID1253949Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Molecular hybridization yields triazole bronchodilators for the treatment of COPD.
AID1147960Octanol-phosphate buffer partition coefficient, Kp of the compound at pH 7.41977Journal of medicinal chemistry, Oct, Volume: 20, Issue:10
Synthesis and preliminary pharmacological activity of aminoalkoxy isosteres of glycolate ester anticholinergics.
AID19650Partition coefficient (logP)2000Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
Synthesis, (18)F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors.
AID1253952Drug metabolism in human liver microsomes assessed as glucuronidation in absence of NADPH and presence of microsomal activator Brij58, UDPGA2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Molecular hybridization yields triazole bronchodilators for the treatment of COPD.
AID1253951Clearance in human liver microsomes2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Molecular hybridization yields triazole bronchodilators for the treatment of COPD.
AID1345364Rat M2 receptor (Acetylcholine receptors (muscarinic))1988The EMBO journal, Oct, Volume: 7, Issue:10
Cloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (67)

TimeframeStudies, This Drug (%)All Drugs %
pre-199041 (61.19)18.7374
1990's16 (23.88)18.2507
2000's9 (13.43)29.6817
2010's1 (1.49)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.43%)5.53%
Reviews2 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other67 (95.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]